Sleep Apnea, Central Recruiting Phase 2 Trials for Acetazolamide (DB00819)

Also known as: Central Sleep Apnea / Sleep Apnea Central / Central sleep apnoea syndrome / Central sleep apnea syndrome (disorder) / Central sleep apnea syndrome

IndicationStatusPhase
DBCOND0003369 (Sleep Apnea, Central)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT06043830Managing Opioid Related Sleep Apnea With AcetazolamideTreatment